Found: 41
Select item for more details and to access through your institution.
Real‐life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 3, p. 1, doi. 10.1002/hon.3273
- By:
- Publication type:
- Article
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study.
- Published in:
- Hematology Reports, 2024, v. 16, n. 1, p. 50, doi. 10.3390/hematolrep16010006
- By:
- Publication type:
- Article
Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 9813, doi. 10.3390/curroncol30110712
- By:
- Publication type:
- Article
Long‐term efficacy in patients with relapsed/refractory diffuse large B‐cell lymphoma achieving a complete response with pixantrone.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 247, doi. 10.1111/ejh.13989
- By:
- Publication type:
- Article
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6111, doi. 10.3390/curroncol30070455
- By:
- Publication type:
- Article
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cells.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1194712
- By:
- Publication type:
- Article
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2753, doi. 10.3390/cancers15102753
- By:
- Publication type:
- Article
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 841, doi. 10.1007/s00277-023-05113-9
- By:
- Publication type:
- Article
The elderly prognostic index predicts early mortality in older patients with diffuse large B‐cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 78, doi. 10.1002/hon.3081
- By:
- Publication type:
- Article
Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the "RTL" (Regional TUSCAN Lymphoma Network)—Authors' reply to Morris and colleagues.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 5, p. 595, doi. 10.1111/ejh.13831
- By:
- Publication type:
- Article
Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the "RTL" (Regional Tuscan Lymphoma network).
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 5, p. 383, doi. 10.1111/ejh.13745
- By:
- Publication type:
- Article
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.835563
- By:
- Publication type:
- Article
The Role of Tumor-Associated Macrophages in Hematologic Malignancies.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3597, doi. 10.3390/cancers13143597
- By:
- Publication type:
- Article
Direct‐acting antivirals in hepatitis C virus‐positive mantle cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 263, doi. 10.1002/hon.2825
- By:
- Publication type:
- Article
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 10, p. 2000, doi. 10.1002/ccr3.3041
- By:
- Publication type:
- Article
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 1, p. 143, doi. 10.1007/s00428-019-02712-8
- By:
- Publication type:
- Article
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
LONG TERM SAFETY AND EFFICACY OF DARATUMUMAB RAPID INTRAVENOUS INFUSION (90 MINUTES) AFTER THE THIRD DOSE IN MULTIPLE MYELOMA PATIENTS.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e147, doi. 10.1016/j.clml.2019.09.246
- By:
- Publication type:
- Article
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience.
- Published in:
- 2019
- By:
- Publication type:
- clinical trial
Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e720, doi. 10.1634/theoncologist.2018-0331
- By:
- Publication type:
- Article
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 2, p. 223, doi. 10.1111/bjh.15582
- By:
- Publication type:
- Article
The significance of serum immunoglobulin paraprotein in diffuse large B‐cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1033, doi. 10.1634/theoncologist.2017-0597
- By:
- Publication type:
- Article
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disorders.
- Published in:
- Journal of Pathology, 2017, v. 242, n. 4, p. 511, doi. 10.1002/path.4914
- By:
- Publication type:
- Article
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 831, doi. 10.1111/bjh.14001
- By:
- Publication type:
- Article
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 6, p. 650, doi. 10.1111/ejh.12732
- By:
- Publication type:
- Article
Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- commentary
Low-dose chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab in follicular lymphoma.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 3, p. 277, doi. 10.1111/ejh.12428
- By:
- Publication type:
- Article
Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 2, p. 186, doi. 10.1111/ejh.12312
- By:
- Publication type:
- Article
Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 2, p. 129, doi. 10.1111/ejh.12315
- By:
- Publication type:
- Article
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 480, doi. 10.1002/ajh.23668
- By:
- Publication type:
- Article
Hodgkin's lymphoma as Richter's transformation in chronic lymphocytic leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 4, p. 213, doi. 10.1002/hon.2038
- By:
- Publication type:
- Article
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 5, p. 590, doi. 10.1111/j.1365-2141.2011.08789.x
- By:
- Publication type:
- Article
13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 8, p. 633, doi. 10.1002/gcc.20885
- By:
- Publication type:
- Article
A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 2, p. 271, doi. 10.1111/j.1365-2141.2011.08602.x
- By:
- Publication type:
- Article
Lack of allelic exclusion by secondary rearrangements of tumour B-cell receptor light chains in hairy cell leukaemia.
- Published in:
- Hematological Oncology, 2011, v. 29, n. 1, p. 31, doi. 10.1002/hon.952
- By:
- Publication type:
- Article
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 3, p. 284, doi. 10.1111/j.1365-2141.2010.08482.x
- By:
- Publication type:
- Article
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 1, p. 64, doi. 10.1111/j.1365-2141.2009.07711.x
- By:
- Publication type:
- Article